Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma

BACKGROUND: The purpose of this study was to assess the safety and efficacy of Yttrium-90 radioembolization using in unresectable hepatocellular carcinoma. METHODS: From 2017 to 2021, 32 patients with unresectable hepatocellular carcinoma, with mean tumor diameter about 7cm (21 males, 11 females; me...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chun-Yen, Huang, Po-Hsun, Tsang, Leo Leung-Chit, Hsu, Hsien-Wen, Lim, Wei-Xiong, Weng, Ching-Chun, Huang, Tung-Liang, Hsu, Chien-Chin, Chen, Chao-Long, Ou, Hsin-You, Cheng, Yu-Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843618/
https://www.ncbi.nlm.nih.gov/pubmed/36660410
http://dx.doi.org/10.2147/JHC.S385478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843618/
https://www.ncbi.nlm.nih.gov/pubmed/36660410
http://dx.doi.org/10.2147/JHC.S385478

Ejemplares similares